Search

Your search keyword '"Franks, PW"' showing total 638 results

Search Constraints

Start Over You searched for: Author "Franks, PW" Remove constraint Author: "Franks, PW"
638 results on '"Franks, PW"'

Search Results

101. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity

102. Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis

103. Genetic studies of body mass index yield new insights for obesity biology

104. New genetic loci link adipose and insulin biology to body fat distribution

105. Consumption of fatty foods and incident type 2 diabetes in populations from eight European countries

106. Different in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study

107. Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct):A validation of existing models

108. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

109. The amount and type of dairy product intake and incident type 2 diabetes:results from the EPIC-InterAct Study

110. A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans

111. Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study

112. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women

113. Lower educational level is a predictor of incident type 2 diabetes in European countries: the EPIC-InterAct study

114. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

115. Diabetes and obesity: leveraging heterogeneity for precision medicine.

116. Subclassification of obesity for precision prediction of cardiometabolic diseases.

118. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.

121. The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study.

122. Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes.

123. A global initiative to deliver precision health in diabetes.

124. Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist.

125. Variability of polygenic prediction for body mass index in Africa.

126. Human Genetic Variation at rs10071329 Correlates With Adiposity-Related Traits, Modulates PPARGC1B Expression, and Alters Brown Adipocyte Function.

127. A Federated Database for Obesity Research: An IMI-SOPHIA Study.

128. Snack quality and snack timing are associated with cardiometabolic blood markers: the ZOE PREDICT study.

129. Genetic variants associated with weight loss and metabolic outcomes after bariatric surgery: A systematic review.

130. Exploring the relationship between social jetlag with gut microbial composition, diet and cardiometabolic health, in the ZOE PREDICT 1 cohort.

131. A Fecal Metabolite Signature of Impaired Fasting Glucose: Results From Two Independent Population-Based Cohorts.

132. Gene-educational attainment interactions in a multi-population genome-wide meta-analysis identify novel lipid loci.

133. Precision medicine for cardiometabolic disease: a framework for clinical translation.

134. Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes.

135. The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries.

136. Glycaemic variability, assessed with continuous glucose monitors, is associated with diet, lifestyle and health in people without diabetes.

137. User preference optimization for control of ankle exoskeletons using sample efficient active learning.

138. Large-scale exome array summary statistics resources for glycemic traits to aid effector gene prioritization.

139. Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review.

140. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.

141. Precision medicine in complex diseases-Molecular subgrouping for improved prediction and treatment stratification.

142. Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits.

143. Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case-cohort study.

144. Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP).

145. Plasma protein N-glycome composition associates with postprandial lipaemic response.

146. Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.

147. Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover.

148. Characterisation of Fasting and Postprandial NMR Metabolites: Insights from the ZOE PREDICT 1 Study.

149. Author Correction: The power of genetic diversity in genome-wide association studies of lipids.

150. Role of sociodemographic, clinical, behavioral, and molecular factors in precision prevention of type 2 diabetes: a systematic review.

Catalog

Books, media, physical & digital resources